383 filings
Page 7 of 20
SC 13D/A
SCNI
Scinai Immunotherapeutics Ltd
11 Jan 22
BiondVax Pharmaceuticals / NACHT MARIUS ownership change
12:47pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
11 Jan 22
Report of Foreign Private Issuer
6:06am
6-K
SCNI
Scinai Immunotherapeutics Ltd
30 Dec 21
Former CFO of GSK’s Global Vaccines Business Mr. Jay Green Joins BiondVax’s Board of Directors
4:15pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
29 Dec 21
Report of Foreign Private Issuer
6:06am
424B5
SCNI
Scinai Immunotherapeutics Ltd
28 Dec 21
Prospectus supplement for primary offering
5:20pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
BiondVax Announces Pricing of $9.0 million Follow-on Underwritten Offering of American Depositary Shares
4:15pm
424B5
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K/A
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
Current report (foreign) (amended)
6:03am
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Dec 21
Report of Foreign Private Issuer
4:15pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
13 Dec 21
Report of Foreign Private Issuer
7:34am
6-K
SCNI
Scinai Immunotherapeutics Ltd
2 Dec 21
BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
4:15pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
24 Nov 21
BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update
3:06pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Nov 21
Report of Foreign Private Issuer
6:05am
6-K
SCNI
Scinai Immunotherapeutics Ltd
12 Nov 21
Report of Foreign Private Issuer
8:22am
6-K
SCNI
Scinai Immunotherapeutics Ltd
25 Oct 21
BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies
6:04am
6-K
SCNI
Scinai Immunotherapeutics Ltd
26 Aug 21
BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update
4:32pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
23 Jun 21
BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update
9:40am
6-K
SCNI
Scinai Immunotherapeutics Ltd
13 May 21
BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results
5:17pm
NT 20-F
SCNI
Scinai Immunotherapeutics Ltd
29 Apr 21
Notice of late annual filing (foreign)
10:05am